Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls

Andreas Hillenbrand,Juliane Fassler,Nadine Huber,Pengfei Xu,Doris Henne-Bruns,Markus Templin,Hubert Schrezenmeier,Anna Maria Wolf,Uwe Knippschild
DOI: https://doi.org/10.1186/1471-2407-12-545
IF: 4.638
2012-01-01
BMC Cancer
Abstract:Background Obesity has been associated with increased incidence of colorectal cancer. Adipose tissue dysfunction accompanied with alterations in the release of adipocytokines has been proposed to contribute to cancer pathogenesis and progression. The aim of this study was to analyze plasma concentrations of several adipose tissue expressed hormones in colorectal cancer patients (CRC) and morbidly obese (MO) patients and to compare these concentrations to clinicopathological parameters. Methods Plasma concentrations of adiponectin, resistin, leptin, active plasminogen activator inhibitor (PAI)-1, monocyte chemotactic protein (MCP)-1, interleukin (IL)-1 alpha, and tumor necrosis factor (TNF)-alpha were determined in 67 patients operated on for CRC (31 rectal cancers, 36 colon cancers), 37 patients operated on for morbid obesity and 60 healthy blood donors (BD). Results Compared to BD, leptin concentrations were lowered in CRC patients whereas those of MO patients were elevated. Adiponectin concentrations were only lowered in MO patients. Concentrations of MCP-1, PAI-1, and IL-1 alpha were elevated in both CRC and MO patients, while resistin and TNF-alpha were similarly expressed in MO and CRC patients compared to BD. Resistin concentrations positively correlated with tumor staging (p<0.002) and grading (p=0.015) of rectal tumor patients. Conclusions The results suggest that both MO and CRC have low-grade inflammation as part of their etiology.
What problem does this paper attempt to address?